OTCMKTS:ODYY

Odyssey Group International Stock Forecast, Price & News

$0.52
+0.01 (+1.96 %)
(As of 08/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.52
$0.54
50-Day Range
$0.51
$0.82
52-Week Range
$0.11
$2.00
Volume24,491 shs
Average Volume100,049 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ODYY News and Ratings via Email

Sign-up to receive the latest news and ratings for Odyssey Group International and its competitors with MarketBeat's FREE daily newsletter.


Odyssey Group International logo

About Odyssey Group International

Odyssey Group International, Inc. focuses on development, acquisition, and commercialization of medical products and health related technologies. It intends to offer medical devices. The company has development projects in three technologies, including CardioMap, a heart monitoring and screening device; Save A Life choking rescue device; and a neurosteroid drug compound intended to treat rare brain disorders. Odyssey Group International, Inc. was founded in 2014 and is based in Irvine, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

2160th out of 2,226 stocks

Medical Devices Industry

21st out of 22 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Odyssey Group International (OTCMKTS:ODYY) Frequently Asked Questions

What stocks does MarketBeat like better than Odyssey Group International?

Wall Street analysts have given Odyssey Group International a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Odyssey Group International wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Odyssey Group International's key executives?

Odyssey Group International's management team includes the following people:
  • Mr. Joseph Michael Redmond, Chairman, Pres, CEO & CFO (Age 60, Pay $161.54k)
  • Ms. Christine M. Farrell, Controller & Sec. (Age 61, Pay $15k)
  • Mr. Michael Contarino, Head of Product Devel. (Age 66)

Who are some of Odyssey Group International's key competitors?

What other stocks do shareholders of Odyssey Group International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Odyssey Group International investors own include Scepter (BRZL), Athersys (ATHX), Fearless Films (FERL), Heat Biologics (HTBX), iBio (IBIO), Pareteum (TEUM), EGF Theramed Health (EVAHF), Health Discovery (HDVY), Onconova Therapeutics (ONTX) and United American Healthcare (UAHC).

What is Odyssey Group International's stock symbol?

Odyssey Group International trades on the OTCMKTS under the ticker symbol "ODYY."

How do I buy shares of Odyssey Group International?

Shares of ODYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Odyssey Group International's stock price today?

One share of ODYY stock can currently be purchased for approximately $0.52.

How many employees does Odyssey Group International have?

Odyssey Group International employs 1 workers across the globe.

What is Odyssey Group International's official website?

The official website for Odyssey Group International is theodysseygroupinternational.com.

How can I contact Odyssey Group International?

The company can be reached via phone at 702-751-1418.


This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.